Kaniah Gunter and Holly Jones
Continue Reading
Karen Alexander: TMA’s 2024 Patient Ambassador Awardee
The Myositis Association (TMA) is thrilled to recognize Karen Alexander, a groundbreaking Black supermodel who was diagnosed with dermatomyositis in 2016. Karen will be honored with TMA’s Heroes in the Fight Patient Ambassador Award on September 7, 2024, in Baltimore, MD. The Myositis Heroes in the Fight Patient Ambassador Award is annually presented by TMA…
Continue Reading
Announcing the Marianne Moyer Myositis Leader Award
The Myositis Association (TMA) is proud to announce the inaugural Marianne Moyer Myositis Leader Award to be presented at the 2024 Heroes in the Fight Awards Celebration on September 7 during our International Annual Patient Conference in Baltimore. The new Marianne Moyer Myositis Leader Award recognizes TMA volunteers who, like Marianne, lead the way in…
Continue Reading
CAR T-cell therapy: A viable option for myositis treatment?
Chimeric antigen receptor T-cell (CAR T-cell) therapy is a process developed to treat certain forms of cancers, especially blood cancers like leukemia and lymphoma. Recently, however, researchers have started exploring its use for autoimmune diseases, including idiopathic inflammatory myositis (IIM). This application is still experimental and not yet available for myositis outside of research studies,…
Continue Reading
Last call for comments for DM PFDD
TMA was honored to partner with Myositis Support and Understanding (MSU) to host the Externally Led Patient Focused Drug Development (PFDD) meeting for adult dermatomyositis (DM) on June 7. View the replay of this important day online. Through the PFDD, we captured DM patients’ experience, perspectives, and needs. The program was designed to inform the…
Continue Reading